Better Coronavirus Stock: Eli Lilly or AbbVie?

Better Coronavirus Stock: Eli Lilly or AbbVie?

Eli Lilly (NYSE: LLY) is a veteran in the pharmaceutical community and has been in business for over 140 years. AbbVie (NYSE: ABBV) is a relative newcomer and was established back in 2013 after spinning off parent organization Abbott Laboratories. Last year was a good one for Eli Lilly.